Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Fungal infections in lab animals can interfere with research.

Systemic lupus erythematosus is a chronic disease causing inflammation and various symptoms, mainly in young women, treated with anti-inflammatory and immunosuppressive drugs.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Effective wound healing after HS treatments can be achieved with various methods like moist dressings and skin grafting.

Tacrolimus can cause hair loss in kidney transplant patients.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Heparin treatment may help manage pemphigus vulgaris in dogs.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Most kidney transplant patients in the study had skin problems, often related to infections, medication side effects, or skin cancer risks.

Inflammation around hair follicles may worsen hair loss; evaluating and treating it can improve transplant results.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

A kidney transplant patient developed leprosy, likely due to immunosuppression and genetic factors, and improved with treatment.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

The virus linked to a rare disease was found in a patient's blood and urine before skin symptoms appeared.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.